Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-064272

EVP, Chief R&D Officer gave up 4,086 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Friberg Gregory R · EVP, Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-30 Shares withheld for taxes : show line 1 in the form −4,086 $60.00 $245,160 47,732 D
Loading xslF345X06/wk-form4_1790886185.xml…